Locally advanced, unresectable or metastatic solid malignancies research hub

The first-in-human trial of MDX-124 in patients with advanced cancer

This clinical trial is testing a new drug called MDX-124 for adults with advanced solid cancers. It is the first time this medicine is being given to humans. Doctors want to find out what dose is safe, how well the body copes with it, and what side effects it causes.